HPV6L1 protein-resisting antibody, preparation method therefor and application thereof
The invention provides an antibody or an antigen bound part which is specifically bound to a human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP. The antibody or the antigen bound part comprises CDR1, CDR2 and CDR3 regions of a heavy chain variable region shown in SEQ ID NO. 1-3 and...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
16.12.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention provides an antibody or an antigen bound part which is specifically bound to a human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP. The antibody or the antigen bound part comprises CDR1, CDR2 and CDR3 regions of a heavy chain variable region shown in SEQ ID NO. 1-3 and CDR1, CDR2 and CDR3 regions of a light chain variable region shown in SEQ ID NO. 4-6. The antibody or the antigen bound part which is specifically bound with the human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP has no cross reactions with most of other HPV sub types such as HPV11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 and the like, is high in specificity, has a characteristic of neutralizing a HPV6 pseudovirus and blocking infection of the pseudovirus, and is high in affinity. A twin-antibody sandwiched ELISA detection kit established by two antibodies can be used for detecting the presence or level of HPV6L1 protein and the antibody can be further used for treatment of patients and passive immunity of susceptible population and has a good application prospect. |
---|---|
AbstractList | The invention provides an antibody or an antigen bound part which is specifically bound to a human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP. The antibody or the antigen bound part comprises CDR1, CDR2 and CDR3 regions of a heavy chain variable region shown in SEQ ID NO. 1-3 and CDR1, CDR2 and CDR3 regions of a light chain variable region shown in SEQ ID NO. 4-6. The antibody or the antigen bound part which is specifically bound with the human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP has no cross reactions with most of other HPV sub types such as HPV11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 and the like, is high in specificity, has a characteristic of neutralizing a HPV6 pseudovirus and blocking infection of the pseudovirus, and is high in affinity. A twin-antibody sandwiched ELISA detection kit established by two antibodies can be used for detecting the presence or level of HPV6L1 protein and the antibody can be further used for treatment of patients and passive immunity of susceptible population and has a good application prospect. |
Author | MA ZHIJING HAN ZIPO CHEN SHI ZHANG JING DU LIFANG LI QIMING GUO SHUYANG |
Author_xml | – fullname: CHEN SHI – fullname: DU LIFANG – fullname: GUO SHUYANG – fullname: MA ZHIJING – fullname: HAN ZIPO – fullname: LI QIMING – fullname: ZHANG JING |
BookMark | eNqNyr8KwjAQgPEMOvin7xB3C42l7lKUDiIO0rXE5mID9e5IbvHtLeoDOH3D71uqGRLCQrXNtd2fjeZIAgHzCCkkCfjQFiXcyb22kwHbaCUQ6ifIQE7LABE8xely2jKPof_6B8iv1dzbMUH260ptTsdb3eTA1EFi2wOCdPXFFJWpyrLYHcp_njdDejtJ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Physics |
ExternalDocumentID | CN105153302A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN105153302A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 16:41:20 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN105153302A3 |
Notes | Application Number: CN20151438587 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151216&DB=EPODOC&CC=CN&NR=105153302A |
ParticipantIDs | epo_espacenet_CN105153302A |
PublicationCentury | 2000 |
PublicationDate | 20151216 |
PublicationDateYYYYMMDD | 2015-12-16 |
PublicationDate_xml | – month: 12 year: 2015 text: 20151216 day: 16 |
PublicationDecade | 2010 |
PublicationYear | 2015 |
RelatedCompanies | NATIONAL VACCINE & SERUM INSTITUTE CO., LTD |
RelatedCompanies_xml | – name: NATIONAL VACCINE & SERUM INSTITUTE CO., LTD |
Score | 3.0120335 |
Snippet | The invention provides an antibody or an antigen bound part which is specifically bound to a human papilloma virus low-risk sub type-type 6 L1 protein and/or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE |
Title | HPV6L1 protein-resisting antibody, preparation method therefor and application thereof |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151216&DB=EPODOC&locale=&CC=CN&NR=105153302A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4g_nxT1Cj-yEzMnlxksHXbw2KkgxAjYzFIeCO068x86IjMGP97rwWEF329a5r1ktt9X3v9CnCrIH7GmLBSFmSWkkC3Aua3LB-JWzb1vYzpPd1-THqvztPYHVfgfXUXRuuEfmlxRMwojvle6v_1bL2JFeneyvk9y9FUPHSHYWQu2bEqXzYxo3bYSQbRgJqUhjQ24xfEuq5CNo3m4xZsI4z2VDZ0Rm11K2W2WVK6h7CT4GyyPIKKkDXYp6uX12qw118eeNdgV3do8jkal1k4P4ZRLxmRZ9vQGgu5tJAxq0yVbwaGKWdF-n2HPrFQ9S6ksXgl2lBQTyBGxVGpsXFwvXAU2QncdDtD2rPwUye_cZnQeL2q1ilUZSHFGRheihZBkKfZ3OENBYC4T9LAmSoy5_JzqP89T_0_5wUcqBirbg6bXEK1_PgUV1iTS3atg_kDKAOQ2w |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4g_sA3RY3ir5mYPbnIBMp4IEY6lqnbIAYX3gjdOjMfOiIzxv_eaxnCi77eNc16ye2-r71-BbiWED9hjBsx6ySGlEA3OsxqGBYSt2RqtROm9nT9gLivzadxa1yC9-VdGKUT-qXEETGjIsz3XP2vZ6tNLFv1Vs5vWYqm7N4ZdW29YMeyfJlEt3vd_nBgD6hOaZcGevCCWLclkU397mEDNhFit2U29MOevJUyWy8pzh5sDXE2ke9DiYsqVOjy5bUq7PjFgXcVtlWHZjRHY5GF8wMI3WFIPFNTGgupMJAxy0wVbxqGKWVZ_H2DPr5Q9c6EtnglWpNQjyNGxVGxtnZwvXBkySFcOf0RdQ381MlvXCY0WK2qcQRlkQl-DFo7RgsnyNPMqBnVJQCKLBJ3mlNJ5lrRCdT-nqf2n_MSKu7I9ybeY_B8Crsy3rKzwyRnUM4_Pvk51uecXajA_gAf25PO |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HPV6L1+protein-resisting+antibody%2C+preparation+method+therefor+and+application+thereof&rft.inventor=CHEN+SHI&rft.inventor=DU+LIFANG&rft.inventor=GUO+SHUYANG&rft.inventor=MA+ZHIJING&rft.inventor=HAN+ZIPO&rft.inventor=LI+QIMING&rft.inventor=ZHANG+JING&rft.date=2015-12-16&rft.externalDBID=A&rft.externalDocID=CN105153302A |